An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition
An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition
Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr. Shinji Ohno, Dr. Rebecca Dent, Prof. Charlie Gourley
DDR and PARPi Expert Forums were held with international faculty in Tokyo and Singapore during January 2020.
Prof. Keiichi Fujiwara
Gynaecologic Oncologist
Saitama Medical University International Medical Center
Japan
Prof. Simon Boulton
Senior Scientist
Francis Crick Institute
United Kingdom (UK)
Dr. Shinji Ohno
Medical Oncologist
Cancer Institute Hospital of JFCR
Japan
Dr. Rebecca Dent
Medical Oncologist
National Cancer Center Singapore
Singapore
Prof. Charlie Gourley
Medical Oncologist
CRUK Edinburgh Centre, Nicola Murray Centre for Ovarian Cancer Re...
United Kingdom (UK)
| 
60 min
|
Jan 2020
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Learn about the role of PARP inhibitors in clinical practice and targeting DDR, including:
-
Mechanism of Action of PARP inhibition and targeting DDR
-
Clinical profile of PARP inhibitors and their benefit in ovarian and breast cancer
-
Appropriate patient selection for PARP inhibition
-
Future DDR and PARP inhibition
Other programmes of interest
0 min
Other programmes developed by Prof. Simon Boulton
Prof. Simon Boulton
Senior Scientist
Francis Crick Institute
United Kingdom (UK)
Other programmes developed by Dr. Rebecca Dent
Dr. Rebecca Dent
Medical Oncologist
National Cancer Center Singapore
Singapore
Other programmes developed by Prof. Charlie Gourley
Prof. Charlie Gourley
Medical Oncologist
CRUK Edinburgh Centre, Nicola Murray Centre for Ovarian Cancer Re...
United Kingdom (UK)